"Loading Stock Price & Valuation Data ..."
Unlock News Summary by Subscribing to iPick.ai Premium!
Ask anything related to PEPG. [ FAQ on what and how to ask] For non-PEPG questions, click the logo in the upper-right corner to return to the main page and ask there.
CEO:Dr. James G. McArthur Ph.D.
Headquarter: 321 Harrison Avenue, 8th Floor, Boston, MA, United States, 02118
Industry: Biotechnology, Investment Track: -, Employees: 56
PepGen Inc., a clinical-stage biotechnology company, develops oligonucleotide therapeutics for the treatment of severe neuromuscular and neurologic diseases in the United States. The company engages in the development of PGN-EDODM1, an EDO peptide-conjugated PMO, which is in Phase 2 clinical trial for the treatment of myotonic dystrophy type 1; and FREEDOM2-DM1, which is in Phase 2 for the treatment of myotonic dystrophy type 1. It is also involved in FREEDOM-OLE, an open label expansion study. The company was founded in 2018 and is based in Boston, Massachusetts.
My Watchlist
